PrEP and Key populations: WHO guidelines & recommendations

Similar documents
HIV in key populations: the global context and agenda

Update on roll out of PrEP

STI and HIV Prevention and Care among Sex Workers

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS

The Evidence Base for Women

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS

On the Fast-Track to end AIDS. HIV & AIDS in the Post 2015 Development Agenda

In collaboration with GLOBAL HEALTH SCIENCES, UNIVERSITY OF CALIFORNIA, SAN FRANCISCO. Training workshop

Which Scale Up Strategies/Programmatic Mixes are most Cost-Effective? Iris Semini UNAIDS May 2018

BUDGET AND RESOURCE ALLOCATION MATRIX

Strengthening the Evidence for HIV Investments: Allocative Efficiency of HIV Responses: Results and Experiences

FPA Sri Lanka Policy: Men and Sexual and Reproductive Health

Direct Clinical Services

Investing for Impact Prioritizing HIV Programs for GF Concept Notes. Lisa Nelson, WHO Iris Semini, UNAIDS

Ravipa Vannakit, USAID Regional Development Mission for Asia (RDMA), Bangkok, Thailand. July 24, 2018

KENYA AIDS STRATEGIC FRAMEWORK 2014/ /2019

Sex Work in Sub-Saharan Africa : Opportunities and Challenges

Advancing Treatment 2.0: Progress on the 2013 Consolidated Guidelines What s new

Sexual and Reproductive Health and HIV. Dr. Rita Kabra Training course in Sexual and Reproductive Health Research Geneva 2012

Counselling Should: Recognize that behaviour change is difficult and human beings are not perfect

PERFORMANCE INDICATOR REFERENCE SHEETS FOR KEY POPULATIONS

Access to Stigma-Free Healthcare Settings for Key Populations: Challenges and Opportunities

Pre-exposure Prophylaxis for HIV Prevention

ACRONYMS AND KEYWORDS

Zero HIV infections Zero HIV deaths Zero HIV stigma. Stephanie Cohen, MD, MPH on behalf of the Getting to Zero Consortium

World Health Organization. A Sustainable Health Sector

WOMEN & HIV: A GLOBAL UPDATE. Deanna Kerrigan, PhD, MPH Associate Professor Health, Behavior & Society

Key populations and HIV

TB/HIV Care s Experience Setting up PrEP Sites and Engaging Potential Service Users. John Mutsambi and Peggy Modikoe TB/HIV Care

INTRODUCTION TIMELINE: PrEP IMPLEMENTATION SA POLICY & GUIDELINES FACILITY AUDIT TOOL IEC MATERIALS MONITORING & EVALUATION

Using anti-hiv drugs for prevention

Strategic use of antiretroviral drugs to prevent HIV transmission

Adherence-enhancing intervention in PrEP in low-resource settings

DEFENDING HUMAN RIGHTS, PROTECTING AGAINST VIOLENCE, PREVENTING HIV/AIDS

Aligning UNICEF s HIV Vision to the SDGs and UNAIDS Strategy. Dr. Chewe Luo Chief, HIV/AIDS Section UNICEF NYHQ 5 April 2016

Regional program of the East Europe and Central Asia Union of PLWH within the framework of the Global Fund New Funding Model

January Treatment Centre. December Drop-In Centre. November Regional Office

PrEP application in the SA Context. Dr Kevi Naidu AWACC 07Oct2016

Place of addiction-informed comprehensive treatment in HIV care

On-going Integrated Strategy Interventions to Maximize ART and PrEP Effectiveness in Peru

Announcement for a Principal Recipient for HIV and TB program Funded by the Global Fund to Fight AIDS, TB and Malaria for

PrEP: Pre Exposure Prophylaxis

Ending the AIDS epidemic by 2030

Lessons from MSM PrEP pilots / demonstration projects. Kevin Rebe

HIV/SRHR Integration for People Living with HIV

DEPARTMENT OF HEALTH RESPONSE TO KEY POPULATIONS

Ethical and Scientific Issues in Prevention Research

ISHTAR - PROGRAMME REVIEW REPORT

Expanding PrEP Access and Implementation in San Francisco

Translating Science to end HIV in Latin America and the Caribbean

HIV and Sexual reproductive health integration: reaching adolescents and young people. What does this (the above) look like for key populations.

FAST-TRACK COMMITMENTS TO END AIDS BY 2030

Lessons learned from Public-Private Partnership The Avahan Experience Sonal Mehta, India HIV/AIDS Alliacne 26 th Oct 2018

Key Populations: Making Them Matter in the Global HIV Response Inextricable Links: HIV and Human Rights

KEY POPULATION PROGRAM IMPLEMENTATION GUIDE JANUARY 2017

PrEP for HIV Prevention. Adult Clinical Guideline from the New York State Department of Health AIDS Institute

Leaving no one behind in Asia and the Pacific. Steven J. Kraus Director UNAIDS Regional Support Team, Asia and the Pacific 28 th January 2015

Uptake of and Retention on HIV Pre-Exposure Prophylaxis (PrEP) among adolescent girls and young women in Kenya

APPLICANT REQUEST FOR MATCHING FUNDS. IMPORTANT: To complete this form, refer to the Instructions for Matching Funds Requests.

Pregnancies amongst adolescents and young women 16% of all births - 19% will have repeat pregnancies before age 20

The global plan to eliminate mother to child transmission (emtct) of HIV: challenges in integration and of therapeutic strategies

Country progress report - Bangladesh. Global AIDS Monitoring 2017

IFMSA Policy Statement Ending AIDS by 2030

Strategic Plan Annual Results Briefing

REACHING ORPHANS AND VULNERABLE CHILDREN WITH CARE & SUPPORT SERVICES IN CÔTE D IVOIRE: EXPERIENCE FROM PROJECT KENEYA

COMMUNITY. Young Sex Workers

targets for HIV-positive children

Getting to zero HIV new infections in Asia and the Pacific region: Possible or impossible dream?

Technical Guidance Note for Global Fund HIV Proposals

PrEP for Women. Together, we can change the course of the HIV epidemic one woman at a time.

Pre exposure Prophylaxis (PrEP): Stepping Up HIV Prevention

Ensuring access to measures for the prevention of motherto-child transmission of HIV in prisons

Implementation of PrEP in Kenya

PrEP Implementation in San Francisco. Michael Barajas- Citywide PrEP Navigator San Francisco City Clinic San Francisco Department of Public Health

Launch of the WHO Consolidated Guidelines on HIV testing services: An overview

Differentiated Care for Antiretroviral Therapy for Key Populations: Case Examples from the LINKAGES Project

TasP and PrEP- Wishful thinking in the developing world?

Definition: Key Populations

GLOBAL AIDS MONITORING REPORT

Successful results of clinical trials

ADDRESSING LEGAL AND POLICY BARRIERS. To Effective HIV Prevention

PRE-EXPOSURE PROPHYLAXIS FOR HIV: EVIDENCE AND GENDER CONSIDERATIONS. Jean R. Anderson M.D. Director, Johns Hopkins HIV Women s Health Program

ETHICS IN HIV PREVENTION RESEARCH IN THE NEW ERA OF

2016 NYS HIV Quality of Care Review

Linkages between Sexual and Reproductive Health and HIV

hiv/aids Programme meeting report March 2012, Siem Reap, Cambodia Executive Summary

Available In person Courses

No adolescent living with HIV left behind: a coalition for action

ACCELERATING HIV COMBINATION PREVENTION HIV COMBINATION PREVENTION INTERVENTIONS

Integrated Behavioral Surveillance Survey among MSM in Bangkok

HIV Resource Allocations using AEM

Sexually Transmitted Infections in Vulnerable Groups. Kevin Rebe

Pre-Exposure Prophylaxis (PrEP) A Biomedical Intervention Prevention with Negatives Antiretroviral Prevention

Supplementary Material Table 5. Ongoing PrEP studies among young key population, young people, and key populations. Age range. Study name and location

HIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons

PrEP Training for Providers in Clinical Settings. (Version 2.0)

As a result of this training, participants will be able to:

Update on global guidelines. and emerging issues on perinatal HIV prevention. WHO 2013 Consolidated ARV Guidelines

Progress toward Universal ART Access: Innovations and Treatment 2.0. Marco Vitoria World Health Organization September 2013

Acknowledgments. G2Z Consortium Shannon Weber Diane Havlir Susan Buchbinder Dana Van Gorder Jeff Sheehy

Transcription:

. PrEP and Key populations: WHO guidelines & recommendations Michelle Rodolph, WHO, HIV Department, Switzerland 24 July 2018 www.who.int

. Evolution of WHO PrEP recommendations (Part I) PrEP for SDC, MSM and Trans people cond l recommendation in the context of demo projects) PrEP for MSM (strong recommendation) Other Key populations (condit l recommendation; no recommendation for PWID) 2012 2014 PrEP for people at substantial HIV risk 3 per 100 person years strong recommendation 2015

. Evolution of WHO PrEP recommendations (Part II) PrEP drugs on EML (TDF/FTC, TDF/3TC, TDF) March 2017 WHO update on PrEP use during pregnancy and breastfeeding July 2017

. not WHO recommendations) WHO PrEP Implementation Tool: practical suggestions Modular Different audiences Different settings and populations Suggestions, not recommendations Learn as implement Frequent updating anticipated July 2017 July 2018

Announcing the launch of the WHO PrEP Implementation Tool App for Health Workers.

Key populations Men who have sex with men Transgender people People who inject drugs People in prisons or other closed settings Sex workers

key Key Population publications Guidelines - Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations - normative and Policy brief - for advocacy 2014, updated in 2016 Young key populations technical briefs Implementation tools SWIT 2013 MSMIT 2015 TransIT 2016 DUIT 2017 Target setting guides PWID 2009, 2012 All KP 2015 Transgender technical update 2015 Case examples: Serving The Needs of Key Populations: Case Examples of Innovation and Good Practice In HIV Prevention, Diagnosis, Treatment and Care 2017

Key populations: comprehensive package of service HIV prevention Harm reduction interventions for people who use drugs HIV testing services HIV treatment and care Prevention, management of co-infections & comorbidities Sexual and reproductive health interventions Supportive legislation, policy and funding Addressing stigma and discrimination Health services available, accessible and acceptable Community empowerment Addressing violence Health interventions Structural interventions WHO positions structural interventions within a comprehensive public health approach Source: WHO Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations

WHO Recommendation on PrEP Oral PrEP (containing TDF) should be offered as an additional prevention choice for people at substantial risk of HIV infection as part of combination prevention approaches. Provide PrEP within combination prevention Condoms and lube Harm reduction HIV testing and linkage to ART Provide PrEP with comprehensive support Adherence counselling Support: Legal, social, emotional support Contraception and reproductive health services For PWID, addition to harm reduction, and not an alternative Which has proven to be extremely effective and cost effective Not implemented (to scale) in most countries

PrEP: key considerations Not for EVERYONE Uptake and continuation is variable Not for ALWAYS Seasons of HIV risk Adherence is critical for PrEP effectiveness Other services beneficial, valued and necessary How to implement strategically Start in the highest incidence areas Start with highest incidence groups KPs (e.g. MSM, TG,) SDC Other populations? Integration and linkages to existing services Many benefits beyond PrEP itself Source: WHO PrEP implementation tool

Acknowledgments WHO HIV Department Shona Dalal Annette Verster Rachel Baggaley Yannis Mameletzis Virginia Macdonald WHO regional and country offices GDG members and reviewers whom have contributed to WHO guidance, Technical briefs and implementation tools on PrEP